Table 1. Neurodegenerative Disease Treatment Drug Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Neurodegenerative Disease Treatment Drug Market Restraints

Table 3. Neurodegenerative Disease Treatment Drug Market Trends

Table 4. Neurodegenerative Disease Treatment Drug Industry Policy

Table 5. Global Neurodegenerative Disease Treatment Drug Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Neurodegenerative Disease Treatment Drug Revenue Market Share by Company (2018-2023)

Table 7. Global Neurodegenerative Disease Treatment Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Neurodegenerative Disease Treatment Drug Mergers & Acquisitions, Expansion Plans

Table 9. Global Neurodegenerative Disease Treatment Drug Manufacturers Product Type

Table 10. China Neurodegenerative Disease Treatment Drug Revenue by Company (2018-2023) & (US$ million)

Table 11. China Neurodegenerative Disease Treatment Drug Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Neurodegenerative Disease Treatment Drug Upstream (Raw Materials)

Table 13. Global Neurodegenerative Disease Treatment Drug Typical Customers

Table 14. Neurodegenerative Disease Treatment Drug Typical Distributors

Table 15. By Type, Global Neurodegenerative Disease Treatment Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Neurodegenerative Disease Treatment Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Neurodegenerative Disease Treatment Drug Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Neurodegenerative Disease Treatment Drug Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Neurodegenerative Disease Treatment Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Neurodegenerative Disease Treatment Drug Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Neurodegenerative Disease Treatment Drug Revenue Market Share, 2018-2029

Table 22. Abbvie Inc. Company Information, Head Office, Market Area and Industry Position

Table 23. Abbvie Inc. Company Profile and Main Business

Table 24. Abbvie Inc. Neurodegenerative Disease Treatment Drug Models, Specifications and Application

Table 25. Abbvie Inc. Neurodegenerative Disease Treatment Drug Revenue and Gross Margin, 2018-2023

Table 26. Abbvie Inc. Recent Developments

Table 27. Amneal Pharmaceuticals Inc. Company Information, Head Office, Market Area and Industry Position

Table 28. Amneal Pharmaceuticals Inc. Company Profile and Main Business

Table 29. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Models, Specifications and Application

Table 30. Amneal Pharmaceuticals Inc. Neurodegenerative Disease Treatment Drug Revenue and Gross Margin, 2018-2023

Table 31. Amneal Pharmaceuticals Inc. Recent Developments

Table 32. Boehringer Ingelheim International Gmbh Company Information, Head Office, Market Area and Industry Position

Table 33. Boehringer Ingelheim International Gmbh Company Profile and Main Business

Table 34. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Models, Specifications and Application

Table 35. Boehringer Ingelheim International Gmbh Neurodegenerative Disease Treatment Drug Revenue and Gross Margin, 2018-2023

Table 36. Boehringer Ingelheim International Gmbh Recent Developments

Table 37. Hoffmann-La Roche Company Information, Head Office, Market Area and Industry Position

Table 38. Hoffmann-La Roche Company Profile and Main Business

Table 39. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Models, Specifications and Application

Table 40. Hoffmann-La Roche Neurodegenerative Disease Treatment Drug Revenue and Gross Margin, 2018-2023

Table 41. Hoffmann-La Roche Recent Developments

Table 42. Merck & Co. Inc. Company Information, Head Office, Market Area and Industry Position

Table 43. Merck & Co. Inc. Company Profile and Main Business

Table 44. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Models, Specifications and Application

Table 45. Merck & Co. Inc. Neurodegenerative Disease Treatment Drug Revenue and Gross Margin, 2018-2023

Table 46. Merck & Co. Inc. Recent Developments

List of Figure

Figure 1. Neurodegenerative Disease Treatment Drug Picture

Figure 2. Global Neurodegenerative Disease Treatment Drug Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Neurodegenerative Disease Treatment Drug Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Neurodegenerative Disease Treatment Drug Market Share of Global

Figure 5. Global Neurodegenerative Disease Treatment Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Neurodegenerative Disease Treatment Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Neurodegenerative Disease Treatment Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Neurodegenerative Disease Treatment Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Neurodegenerative Disease Treatment Drug Industry Chain

Figure 10. N-methyl-D-aspartate Receptor antagonists

Figure 11. Cholinesterase Inhibitors

Figure 12. Dopamine Agonists

Figure 13. Immunomodulatory Drugs

Figure 14. Others

Figure 15. By Type, Global Neurodegenerative Disease Treatment Drug Revenue, 2018-2029, US$ Million

Figure 16. By Type, Global Neurodegenerative Disease Treatment Drug Revenue Market Share, 2018-2029

Figure 17. Hospital

Figure 18. Clinic

Figure 19. Others

Figure 20. By Application, Global Neurodegenerative Disease Treatment Drug Revenue, 2018-2029, US$ Million

Figure 21. By Application, Global Neurodegenerative Disease Treatment Drug Revenue Market Share, 2018-2029

Figure 22. By Region, Global Neurodegenerative Disease Treatment Drug Revenue Market Share, 2018-2029

Figure 23. North America Neurodegenerative Disease Treatment Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, North America Neurodegenerative Disease Treatment Drug Revenue Market Share, 2018-2023

Figure 25. Europe Neurodegenerative Disease Treatment Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 26. By Country, Europe Neurodegenerative Disease Treatment Drug Revenue Market Share, 2018-2023

Figure 27. Asia Pacific Neurodegenerative Disease Treatment Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 28. By Country/Region, Asia Pacific Neurodegenerative Disease Treatment Drug Revenue Market Share, 2018-2023

Figure 29. South America Neurodegenerative Disease Treatment Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 30. By Country, South America Neurodegenerative Disease Treatment Drug Revenue Market Share, 2018-2023

Figure 31. Middle East & Africa Neurodegenerative Disease Treatment Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 32. U.S. Neurodegenerative Disease Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 33. By Company, U.S. Neurodegenerative Disease Treatment Drug Market Share, 2018-2023

Figure 34. By Type, U.S. Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 35. By Application, U.S. Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 36. Europe Neurodegenerative Disease Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 37. By Company, Europe Neurodegenerative Disease Treatment Drug Market Share, 2018-2023

Figure 38. By Type, Europe Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 39. By Application, Europe Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 40. China Neurodegenerative Disease Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 41. By Company, China Neurodegenerative Disease Treatment Drug Market Share, 2018-2023

Figure 42. By Type, China Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 43. By Application, China Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 44. Japan Neurodegenerative Disease Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 45. By Company, Japan Neurodegenerative Disease Treatment Drug Market Share, 2018-2023

Figure 46. By Type, Japan Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 47. By Application, Japan Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 48. South Korea Neurodegenerative Disease Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 49. By Company, South Korea Neurodegenerative Disease Treatment Drug Market Share, 2018-2023

Figure 50. By Type, South Korea Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 51. By Application, South Korea Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 52. Southeast Asia Neurodegenerative Disease Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 53. By Company, Southeast Asia Neurodegenerative Disease Treatment Drug Market Share, 2018-2023

Figure 54. By Type, Southeast Asia Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 55. By Application, Southeast Asia Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 56. India Neurodegenerative Disease Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 57. By Company, India Neurodegenerative Disease Treatment Drug Market Share, 2018-2023

Figure 58. By Type, India Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 59. By Application, India Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 60. Middle East & Asia Neurodegenerative Disease Treatment Drug Revenue, 2018-2029, (US$ Million)

Figure 61. By Company, Middle East & Asia Neurodegenerative Disease Treatment Drug Market Share, 2018-2023

Figure 62. By Type, Middle East & Asia Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 63. By Application, Middle East & Asia Neurodegenerative Disease Treatment Drug Revenue Market Share, 2022 VS 2029

Figure 64. Research Methodology

Figure 65. Breakdown of Primary Interviews

Figure 66. Bottom-up Approaches

Figure 67. Top-down Approaches